Results 171 to 180 of about 56,666 (257)

Evidence‐Based Nursing Management During Mavacamten Therapy in an 89‐Year‐Old Patient With Symptomatic Hypertrophic Obstructive Cardiomyopathy: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT In older patients receiving mavacamten, a reduction in NT‐proBNP levels may coexist with persistent severe LVOTO. Nurses should interpret this biomarker–echocardiography discordance as a safety signal and maintain structured cardiovascular surveillance rather than assuming treatment success based solely on biomarker improvement.
Feifei Wang
wiley   +1 more source

Intricacies in Serial Electrocardiograms in a Patient With Takotsubo Syndrome Mimicking Apical Hypertrophic Cardiomyopathy

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Some patients with takotsubo syndrome reveal transiently features of hypertrophic cardiomyopathy at imaging, particularly of the apical variety; this “pseudohypertrophy” is due to myocardial edema, and can be diagnosed by the absence of electrocardiogram evidence of left ventricular hypertrophy, and particularly a transient reduction of the ...
John E. Madias
wiley   +1 more source

Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy. [PDF]

CJC Open
Mehta A, Schumacher S, Bhansali RA, Kwapong YA, Kim YJ, Adebowale O, Vaught AJ, Awais Z, Sheikh FH, Michos ED, Madrazo J, Hays AG, Minhas AS.   +12 more
europepmc   +1 more source

Recurrent and Progressive CAVB After Alcohol Septal Ablation for HOCM: Bridging Therapy With a Semi‐Permanent Pacemaker

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT In patients undergoing alcohol septal ablation for hypertrophic obstructive cardiomyopathy, complete atrioventricular block can be delayed and recurrent. A semi‐permanent pacemaker serves as an effective bridging therapy, allowing for extended monitoring of conduction recovery and may spare selected patients from permanent device implantation.
Enyuan Zhang, Le He, Henan Zhang, Jing Xu, Fengmin Lu, Dongyan Wu, Yitong Yin, Wei Ma   +7 more
wiley   +1 more source

Toward a Comprehensive Understanding of Obstructive Hypertrophic Cardiomyopathy

JACC: Basic to Translational Science
Ahmad Masri, MD, MS
doaj   +1 more source

Impact of Severe Postoperative Multi‐Organ Dysfunction on Long‐Term Outcomes After Modified Morrow Surgery

Clinical Cardiology, Volume 49, Issue 8, August 2026.
This retrospective cohort study (n = 380) demonstrates that severe postoperative multi‐organ dysfunction (SOFA Maximum ≥ 11) is a strong independent predictor of long‐term adverse outcomes after modified Morrow surgery. Incorporating the SOFA score into postoperative assessments helps identify high‐risk hypertrophic obstructive cardiomyopathy patients ...
Tong Wang, La Ta, Kui Zhang, Ran Dong, Yu Xiao, Jiayang Wang   +5 more
wiley   +1 more source

Hypertrophic Cardiomyopathy With Evolution to a Mixed Hypertrophic Noncompaction Phenotype. [PDF]

JACC Case Rep
Abadi NE, Abadi CA.
europepmc   +1 more source

Identification of Prognostic Genes Relevant With the Nuclear Factors of Activated T Cells Based on Transcriptomics in Oral Squamous Cell Carcinoma

Clinical and Experimental Dental Research, Volume 12, Issue 4, August 2026.
ABSTRACT Background It has previously been demonstrated that the nuclear factor of activated T cells (NFAT) is crucial for the development of tumors. Given OSCC's drug resistance and poor outcomes, identifying NFAT‐associated prognostic genes is urgent for better treatment.
Julaiti Tuerxun, Ailimaierdan Ainiwaer, Tairan Ding   +2 more
wiley   +1 more source

Myosin Inhibition in Non-obstructive Hypertrophic Cardiomyopathy: Lessons from ODYSSEY-HCM. [PDF]

Eur Cardiol
Hasegawa K, Iguchi M, Wada H, Dan GA.
europepmc   +1 more source